With an emphasis on effective and economic patient care, Ayrtons has a portfolio of trusted treatments.

  • Glytrin Ret

    Glytrin Spray

    400µg per metered dose oro-mucosal (sublingual) spray solution of Glyceryl Trinitrate (GTN) for the treatment of acute angina pectoris and prevention of inducible angina. 

  • Spilonret

    Sprilon Spray

    Cutaneous spray of Zinc Oxide 12.5% w/w and Dimeticone 1.04% w/w for the prevention and treatment of pressure sores and skin damage from body fluids, protection and treatment of fissures and leg ulcers and protection of skin beneath plaster casts. 

  • Betadine Ret

    Betadine Dry Powder Spray

    Pressurised aerosol spray containing Povidone Iodine 2.5% w/w for the treatment and prevention of infection in wounds, including ulcers, burns, cuts and other minor injuries.


Ayrtons is investing in new products and is interested in collaborating in the co-development, in/out-licensing and distribution internationally of aerosol products (in particular for respiratory, wound/skin, cardiac and systemic treatments) and other high value products for speciality, novel and niche markets.